Cargando…
Inhibition of acetylation of histones 3 and 4 attenuates aortic valve calcification
Aortic valve calcification develops in patients with chronic kidney disease who have calcium and phosphate metabolic disorders and poor prognoses. There is no effective treatment except valve replacement. However, metabolic disorders put patients at high risk for surgery. Increased acetylation of hi...
Autores principales: | Gu, Jia, Lu, Yan, Deng, Menqing, Qiu, Ming, Tian, Yunfan, Ji, Yue, Zong, Pengyu, Shao, Yongfeng, Zheng, Rui, Zhou, Bin, Sun, Wei, Kong, Xiangqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802657/ https://www.ncbi.nlm.nih.gov/pubmed/31292436 http://dx.doi.org/10.1038/s12276-019-0272-9 |
Ejemplares similares
-
SPARC-related modular calcium binding 1 regulates aortic valve calcification by disrupting BMPR-II/p-p38 signalling
por: Wang, Yaqing, et al.
Publicado: (2021) -
MicroRNA Expression Signature in Human Calcific Aortic Valve Disease
por: Wang, Hui, et al.
Publicado: (2017) -
Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification
por: Choi, Bongkun, et al.
Publicado: (2021) -
Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling
por: Su, Zhongping, et al.
Publicado: (2020) -
Upregulated microRNA-330-3p promotes calcification in the bicuspid aortic valve via targeting CREBBP
por: Zheng, Rui, et al.
Publicado: (2020)